Cristina Larkin, Chief Operating Officer at Spero Therapeutics, Inc. (SPRO), sold 4,000 shares at $17.50 ($70K) on 2018-07-05, disclosed to the SEC on 2018-07-06.
Open-market sale of $70k SPRO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |